...
首页> 外文期刊>Oxidative Medicine and Cellular Longevity >Effect of the Antihypertensive Drug Enalapril on Oxidative Stress Markers and Antioxidant Enzymes in Kidney of Spontaneously Hypertensive Rat
【24h】

Effect of the Antihypertensive Drug Enalapril on Oxidative Stress Markers and Antioxidant Enzymes in Kidney of Spontaneously Hypertensive Rat

机译:降压药依那普利对自发性高血压大鼠肾脏氧化应激指标和抗氧化酶的影响

获取原文
           

摘要

Oxidative stress has been suggested to play a role in hypertension and hypertension induced organ damage. This study examined the effect of enalapril, an antihypertensive drug, on oxidative stress markers and antioxidant enzymes in kidney of spontaneously hypertensive rat (SHR) and Nω-nitro-L-arginine methyl ester (L-NAME) administered SHR. Male rats were divided into four groups (SHR, SHR+enalapril, SHR+L-NAME, and SHR+enalapril+L-NAME). Enalapril (30 mg kg−1day−1) was administered from week 4 to week 28 and L-NAME (25 mg kg−1day−1) was administered from week 16 to week 28 in drinking water. Systolic blood pressure (SBP) was measured during the experimental period. At the end of experimental periods, rats were sacrificed; urine, blood, and kidneys were collected for the assessment of creatinine clearance, total protein, total antioxidant status (TAS), thiobarbituric acid reactive substances (TBARS), superoxide dismutase (SOD), and catalase (CAT), as well as histopathological examination. Enalapril treatment significantly enhanced the renal TAS level (P<0.001) and SOD activity (P<0.001), reduced the TBARS levels (P<0.001), and also prevented the renal dysfunction and histopathological changes. The results indicate that, besides its hypotensive and renoprotective effects, enalapril treatment also diminishes oxidative stress in the kidneys of both the SHR and SHR+L-NAME groups.
机译:已经提出氧化应激在高血压和高血压引起的器官损伤中起作用。这项研究检查了降压药依那普利对自发性高血压大鼠(SHR)和Nω-硝基-L-精氨酸甲酯(L-NAME)给予的SHR肾脏氧化应激标志物和抗氧化酶的影响。将雄性大鼠分为四组(SHR,SHR +依那普利,SHR + L-NAME和SHR +依那普利+ L-NAME)。在饮用水的第4周至第28周给予Enalapril(30μmgkg-1day-1),从第16周至第28周给予L-NAME(25μmgkg-1day-1)。在实验期间测量收缩压(SBP)。实验结束时,处死大鼠。收集尿液,血液和肾脏以评估肌酐清除率,总蛋白,总抗氧化剂状态(TAS),硫代巴比妥酸反应性物质(TBARS),超氧化物歧化酶(SOD)和过氧化氢酶(CAT)以及组织病理学检查。依那普利治疗显着提高了肾脏TAS水平(P <0.001)和SOD活性(P <0.001),降低了TBARS水平(P <0.001),还预防了肾功能不全和组织病理学改变。结果表明,依那普利治疗除了具有降压和肾保护作用外,还可以减轻SHR和SHR + L-NAME组肾脏的氧化应激。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号